Rosuvastatin stimulates clonogenic potential and anti-inflammatory properties of endothelial progenitor cells

Cell Biology International

Volumn 34, Issue 7, 2010, Pages 709-715

  Fadini, Gian Paolo ^a   Albiero, Mattia ^a   Boscaro, Elisa ^a   Menegazzo, Lisa ^a   Cabrelle, Anna ^a   Piliego, Teodoro ^b   Federici, Massimo ^c   Agostini, Carlo ^a   Avogaro, Angelo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Astra Zeneca Medical Division   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Endothelium; Regeneration; Statin; Stem cell

Indexed keywords

CD163 ANTIGEN; CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; ROSUVASTATIN; DIFFERENTIATION ANTIGEN; FLUOROBENZENE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRIMIDINE DERIVATIVE; SULFONAMIDE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD DONOR; CELL ADHESION; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; CELL STIMULATION; CLONOGENESIS; COLONY FORMING UNIT; COLONY FORMING UNIT F; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MALE; MONOCYTE; MONONUCLEAR CELL; NORMAL HUMAN; POLARIZATION; STEM CELL; CELL POLARITY; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; PHYSIOLOGY;

ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL POLARITY; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PYRIMIDINES; STEM CELLS; SULFONAMIDES;

EID: 77955314678     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20090473     Document Type: Article

References (34)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7.
2. Assmus B, Urbich C, Aicher A, Hofmann WK, Haendeler J, Rossig L et al. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res 2003;92:1049-55.
3. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001;108:391-7.
4. Fadini GP, Agostini C, Avogaro A. Characterization of endothelial progenitor cells. Biochem Biophys Res Commun 2005;336:1-2.
5. + cells, metabolic syndrome, and cardiovascular risk. Eur Heart J 2006a;27:2247-55.
6. Fadini GP, Sartore S, Albiero M, Baesso I, Murphy E, Menegolo M, Grego F, Vigili de Kreutzenberg S, Tiengo A, Agostini C, Avogaro A. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 2006b;26:2140-6.
7. Fadini GP, Agostini C, Sartore S, Avogaro A. Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 2007;194:46-54.
8. Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, Avogaro A. Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 2008a;197:496-503.
9. Fadini GP, de Kreutzenberg S, Albiero M, Coracina A, Pagnin E, Baesso I et al. Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol 2008b;28:997-1004.
10. Fadini GP, Albiero M, Cignarella A, Bolego C, Pinna C, Boscaro E, Pagnin E, de Toni R, de Kreutzenberg S, Agostini C, Avogaro A. Effects of androgens on endothelial progenitor cells in vitro and in vivo. Clin Sci 2009;117:335-64.
11. Fadini GP, Agostini C, Avogaro A. Autologous stem cell therapy for peripheral arterial disease. Meta-analysis and systematic review of the literature. Atherosclerosis 2010;209:10-7.
12. Heil M, Ziegelhoeffer T, Mees B, Schaper W. A different outlook on the role of bone marrow stem cells in vascular growth. Bone marrow delivers software not hardware. Circ Res 2004;94:573-4.
13. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
14. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004;24:288-93.
15. Ingram DA, Caplice NM, Yoder MC. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 2005;106:1525-31.
16. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004;104:2752-60.
17. Kim SJ, Kim JS, Papadopoulos J, Wook Kim S, Maya M, Zhang F et al. Circulating monocytes expressing CD31: implications for acute and chronic angiogenesis. Am J Pathol 2009;174:1972-80.
18. Kim SY, Oh HK, Ha JM, Ahn HY, Shin JC, Baek SH et al. RGD-peptide presents anti-adhesive effect, but not direct pro-apoptotic effect on endothelial progenitor cells. Arch Biochem Biophys 2007;459:40-9.
19. Kostapanos MS, Milionis HJ, Elisaf MS. An overview of the extra-lipid effects of rosuvastatin. J Cardiovasc Pharmacol Ther 2008;13: 157-74.
20. Lipinski MJ, Biondi-Zoccai GG, Abbate A, Khianey R, Sheiban I, Bartunek J et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 2007;50:1761-7.
21. Mantovani A, Locati M. Orchestration of macrophage polarization. Blood 2009;114:3135-6.
22. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004;25:677-86.
23. McTaggart F. Comparative pharmacology of rosuvastatin. Atheroscler Suppl 2003;4:9-14.
24. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007;204:3037-47.
25. Prokopi M, Pula G, Mayr U, Devue C, Gallagher J, Xiao Q et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 2009;114:723-32.
26. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207.
27. Rohde E, Bartmann C, Schallmoser K, Reinisch A, Lanzer G, Linkesch W et al. Immune cells mimic the morphology of endothelial progenitor colonies in vitro. Stem Cells 2007;25:1746-52.
28. Urbich C, Dernbach E, Zeiher AM, Dimmeler S. Double-edged role of statins in angiogenesis signaling. Circ Res 2002;90:737-44.
29. Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM, Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 2003;108: 2511-6.
30. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, Dimmeler S. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001a;103:2885-90.
31. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001b;89:E1-7.
32. Werner N, Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? Arterioscler Thromb Vasc Biol 2006;26:257-66.
33. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007;109:1801-9.
34. Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh IY et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005;112:1618-27.